ArticleFrontiers in medicine2024

Sirolimus treatment for intractable lymphatic anomalies: an open-label, single-arm, multicenter, prospective trial.

Michio Ozeki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.